93 related articles for article (PubMed ID: 8744792)
1. Breast cancer; tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis.
Thorgeirsson UP; Yoshiji H; Sinha CC; Gomez DE
In Vivo; 1996; 10(2):137-44. PubMed ID: 8744792
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion.
Stearns ME; Rhim J; Wang M
Clin Cancer Res; 1999 Jan; 5(1):189-96. PubMed ID: 9918218
[TBL] [Abstract][Full Text] [Related]
3. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.
Padgett LC; Lui GM; Werb Z; LaVail MM
Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Jones JL; Glynn P; Walker RA
J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
10. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.
Johnson MD; Kim HR; Chesler L; Tsao-Wu G; Bouck N; Polverini PJ
J Cell Physiol; 1994 Jul; 160(1):194-202. PubMed ID: 7517405
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Bendrik C; Robertson J; Gauldie J; Dabrosin C
Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
[TBL] [Abstract][Full Text] [Related]
13. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Duivenvoorden WC; Hirte HW; Singh G
Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
[TBL] [Abstract][Full Text] [Related]
14. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.
Taraboletti G; Sonzogni L; Vergani V; Hosseini G; Ceruti R; Ghilardi C; Bastone A; Toschi E; Borsotti P; Scanziani E; Giavazzi R; Pepper MS; Stetler-Stevenson WG; Bani MR
Exp Cell Res; 2000 Aug; 258(2):384-94. PubMed ID: 10896789
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
16. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
Kugler A; Hemmerlein B; Thelen P; Kallerhoff M; Radzun HJ; Ringert RH
J Urol; 1998 Nov; 160(5):1914-8. PubMed ID: 9783985
[TBL] [Abstract][Full Text] [Related]
17. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.
Ribeiro-Silva A; Ribeiro do Vale F; Zucoloto S
Am J Clin Pathol; 2006 Apr; 125(4):512-8. PubMed ID: 16627261
[TBL] [Abstract][Full Text] [Related]
20. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis.
Martin DC; Sanchez-Sweatman OH; Ho AT; Inderdeo DS; Tsao MS; Khokha R
Lab Invest; 1999 Feb; 79(2):225-34. PubMed ID: 10068210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
